TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharma Nord ApS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
65,240
|
60,029
|
59,094 |
| Earnings before taxes |
5,269
|
3,492
|
5,793 |
| Total assets |
54,334
|
57,306
|
60,112 |
| Current assets |
24,715
|
30,343
|
35,033 |
| Current liabilities |
26,551
|
26,891
|
26,315 |
| Equity capital |
19,215
|
21,544
|
24,613 |
| - share capital |
27
|
27
|
27 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
35.4%
|
37.6%
|
40.9% |
| Turnover per employee |
435
|
400
|
394 |
| Profit as a percentage of turnover |
8.1%
|
5.8%
|
9.8% |
| Return on assets (ROA) | |||
| Current ratio |
93.1%
|
112.8%
|
133.1% |
| Return on equity (ROE) |
27.4%
|
16.2%
|
23.5% |
| Change turnover |
5,268
|
1,067
|
-4,134 |
| Change turnover % |
9%
|
2%
|
-7% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.